| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 202.170 | 209.643 | 213.634 | 211.537 | 152.932 | 86.317 | 116.800 | 121.640 | 143.532 | 164.528 |
| Total Income - EUR | 203.167 | 209.660 | 213.678 | 211.537 | 153.265 | 107.177 | 117.760 | 126.839 | 146.120 | 164.904 |
| Total Expenses - EUR | 193.325 | 202.331 | 207.399 | 207.131 | 149.805 | 101.311 | 116.030 | 119.988 | 128.966 | 168.894 |
| Gross Profit/Loss - EUR | 9.842 | 7.329 | 6.279 | 4.407 | 3.460 | 5.865 | 1.729 | 6.851 | 17.155 | -3.990 |
| Net Profit/Loss - EUR | 5.542 | 3.707 | 2.618 | 2.228 | 1.924 | 5.154 | 949 | 5.816 | 15.925 | -7.539 |
| Employees | 13 | 13 | 12 | 10 | 9 | 7 | 7 | 7 | 7 | 6 |
Check the financial reports for the company - Splendia Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 51.611 | 35.163 | 16.811 | 8.421 | 5.361 | 1.483 | 853 | 305 | 43 | 0 |
| Current Assets | 39.816 | 31.524 | 41.649 | 54.449 | 54.510 | 45.628 | 32.667 | 34.310 | 38.570 | 32.919 |
| Inventories | 24.020 | 22.161 | 31.344 | 46.201 | 49.748 | 41.875 | 29.319 | 31.029 | 33.258 | 20.821 |
| Receivables | 15.533 | 8.566 | 7.781 | 6.366 | 2.214 | 3.352 | 2.695 | 2.309 | 2.988 | 6.290 |
| Cash | 263 | 797 | 2.524 | 1.882 | 2.549 | 401 | 653 | 972 | 2.324 | 5.808 |
| Shareholders Funds | -12.419 | -8.585 | -5.822 | -3.487 | -1.495 | 3.687 | 4.554 | 10.384 | 26.949 | 19.260 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 103.959 | 75.385 | 64.394 | 66.466 | 61.472 | 43.529 | 29.067 | 24.333 | 11.765 | 13.760 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Splendia Medica S.r.l.